ImmunotherapyImmunotherapy has revolutionized the management of patients with cancer, achieving better clinical results with limited side effects compared with conventional therapies, but in a limited subset of
Immunotherapy is a promising new form of cancer treatment, but the supercharged immune cells it employs can become exhausted in the fight. Researchers in Japan have found a way to keep them going for longer, by rejuvenating them with stem cells.
Immunotherapy has transformed cancer treatment, providing new hope for cancers once deemed incurable by harnessing the immune system to fight the disease. However, many cancers can evade immune attacks, leading to resistance against these treatments. Researchers led by Anna Obenauf at the IMP have i...
“Cancer is like a person’s thumbprint; each person’s cancer is uniquely theirs,” says Bill Hearl, CEO of Immunomic Therapeutics, a clinical stage biotechnology company developing a nucleic acid immunotherapy platform with the potential to treat cancer, allergies and animal health issues. New ...
Aiming to increase efficacy of surgical solutions and patient outcome, immunotherapy for rare cancers is becoming a more viable option, providing much-needed hope and treatments for patients. With this study and others, immunotherapy is poised to transform rare cancer treatment and provide hope for ...
improves the function of immune system cells along with all other cells in the body. This will enable the immune system to better fight cancer. Also, the instructions direct the immune system to eliminate cancer from the body. These instructions activate the immune system response against cancer....
Survival rates for brain cancer vary depending on the type of tumor Fighting brain cancer with immunotherapy 02:13 On Monday the White House website created a virtual condolence book so the public can send notes of sympathy to the family of Beau Biden. The vice president's son, who was ...
The ability to repress multiple immunosuppressive pathways, and to do so in both tumor cells and non-cancerous cells in the TME, means T-win is a unique approach that could open new possibilities in immunotherapy. "With our T-win approach we are able to recalibrate the impact of the ...
Adjusting the scope of natural killer cells in cancer therapy Article Open access 23 May 2025 Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders Article 21 March 2022 Roles of natural killer cells in immunity to cancer, and applications to immunotherapy ...
Watson’s study of how to leverage Tregcells’ metabolic flexibility to boost the body’s antitumor response stands out—so much that his research earned him a spot on the 2017 Society for Immunotherapy of Cancer (SITC) conference’s roster of speakers. That’s quite an achieveme...